VIP and rheumatoid arthritis: Moreover, VIP is able to downregulate the enhanced expression of the IL-22 specific receptor, preventing the IL-22 stimulatory effects on proliferation and production of matrix metalloproteinase-1 (MMP-1) and S100A8/A9 alarmins involved in RA-SF mediated joint destruction [206].